ALERTS (AngelMed Implantable Monitor for Early Recognition and Treatment of ST Elevation MI)
OSIRIS: Prochymal (cultured adult human mesenchymal stem cells) intravenous infusion following acute MI
PFO Access: Documented PFO who have experienced at least two cryptogentic strokes.
ROCHE: To evaluate the potential of RO4607381 to reduce cardiovascular morbidity and mortality in stable CHD patients, with a documented recent ACS.
SATURN: Effects of Rosuvastatin 40 mg and Atorvastatin 80 mg on the percent atheroma volume of a coronary artery as measured by IVUS in patients with CAD.
Note: For additional information on any trial please contact the Nurse Coordinator as listed above.
